Tag: hidradenitis
Bimekizumab Phase 3 Data in Hidradenitis Suppurativa Show Clinically Meaningful,… –...
Patients treated with investigational bimekizumab, an IL-17A and IL-17F inhibitor, achieved statistically significant and clinically meaningful improvements over placebo in signs and symptoms...
Patients with hidradenitis suppurativa experienced sustained efficacy and sympto… – Press...
In two of the largest Phase III trials conducted in hidradenitis suppurativa (HS), Cosentyx® (secukinumab) treatment response rates continued to improve beyond the...